Relative high protein abundance of endogenous K-Ras4B in long-term cultures and primary cultures (GBM, WHO grade 4) were assessed by semiquantitative western blot analysis with a panel of commercial antibodies specific for KRAS4B [50] (data not shown). This evidence concerns the gene KRAS and glioblastoma.